How Big Is the Ibuprofen API Market | Segments & Forecast 2025

Code: MTA6844 Publication Date: Jul 2025

How big is the Ibuprofen API Market?

According to 6Wresearch internal database and industry insights, the Global Ibuprofen API Market was valued at USD 1.5 Billion in 2024 and is projected to reach USD 2.18 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.60% during the forecast period of 2025–2031.

The market growth is driven by the rising demand for non-prescription analgesics, increasing self-medication trends, and a growing elderly population suffering from chronic pain and inflammation.

Key Growth Drivers of the Ibuprofen API Market

  • Growing global demand for over-the-counter (OTC) pain relief medications
  • Expanding geriatric population with arthritis and joint disorders
  • Increased cases of headaches, fever, and inflammation-related ailments
  • Rising healthcare expenditure in developing nations
  • Stable manufacturing costs and readily available raw materials

Ibuprofen API Market Trends

The ibuprofen API market is witnessing sustained growth due to the increasing preference for non-steroidal anti-inflammatory drugs (NSAIDs) for common ailments. Manufacturers are focusing on enhancing production capacity to meet global supply chain demands. In addition, there is a growing trend of outsourcing API production to countries like India and China due to cost-efficiency and strong chemical manufacturing infrastructure. E-commerce pharmacies and OTC product availability have made ibuprofen-based products more accessible, especially in remote and rural areas.

Emerging Developments in the Ibuprofen API Market

Continuous manufacturing Though still in its infancy in technology, continuous manufacturing processes are cutting the time involved in the manufacture of products as well as increasing product consistency. New business opportunities are also coming up in the form of regulatory approvals in Europe and the US of new formulations. The pharmaceutical industries are pursuing more sustainable and greener synthesis paths. Partnerships and mergers between API manufacturers and finished dosages form companies will also aid strengthening of the market.

Major Companies in the Ibuprofen API Market

  • IOL Chemicals and Pharmaceuticals Ltd.
  • BASF SE
  • Xinhua Pharmaceutical Co., Ltd.
  • SI Group, Inc.
  • Solara Active Pharma Sciences
  • Granules India Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Hubei Bio cause Pharmaceutical Co., Ltd.
  • Sri Krishna Pharmaceuticals Ltd.
  • Anqiu Lu'an Pharmaceutical Co., Ltd.

How Big Is the Ibuprofen API Market : FAQ's

It was valued at USD 1.5 Billion in 2024 and is projected to reach USD 2.18 Billion by 2031.
The ibuprofen API market is expected to grow at a CAGR of 5.60% from 2025 to 2031.
Increased use of OTC pain relievers, aging population, and rising healthcare awareness.
Used in tablets, capsules, syrups, and topical formulations for pain and inflammation relief.
Asia-Pacific dominates due to robust API manufacturing infrastructure and exports.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All